Artwork

Content provided by Jeffrey Stewart. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jeffrey Stewart or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Patient Assistance: The Best Deal in Pharma

29:10
 
Share
 

Manage episode 414083146 series 2286377
Content provided by Jeffrey Stewart. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jeffrey Stewart or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Patient assistance programs can make a huge difference for patients who need expensive medicines but can't afford them.

In this episode, Jeff Stewart talks with Dave MacLeod, Managing Director, Value & Access at Syneos Health about the benefits and challenges of patient assistance programs, which provide free or low-cost medicines to eligible patients. They discuss how these programs can improve access, adherence, and outcomes, as well as the operational and regulatory issues involved in running them. Covering key topics such as the Inflation Reduction Act (IRA), the impact of technology and AI in patient services, and the challenges posed by copay accumulators and maximizers, Dave sheds light on the complexities of navigating copay assistance optimization and the strategies employed to mitigate the effects on patients and manufacturers alike.

For more from our Value & Access experts, check out these topics:

Syneos Health Podcast | Real Talk About the Inflation Reduction Act

BLOG: Industry Cheers “Co-Pay Accumulator” Ruling, Should Prep for What’s Next

Potential Impact of European Pharma Legislation on Commercialization and Access of New Therapies

BLOG: What Can We Learn From ICER's New Value Framework

Syneos Health Podcast | Market Access for Weight Loss Drugs

MM+M Podcast | Gaining Access and Delivering Pull-Through in IDNs and Key Accounts

The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.
If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at insightshub.health.
Like what you’re hearing? Be sure to rate and review us!
We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at podcast@syneoshealth.com.

  continue reading

145 episodes

Artwork
iconShare
 
Manage episode 414083146 series 2286377
Content provided by Jeffrey Stewart. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jeffrey Stewart or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Patient assistance programs can make a huge difference for patients who need expensive medicines but can't afford them.

In this episode, Jeff Stewart talks with Dave MacLeod, Managing Director, Value & Access at Syneos Health about the benefits and challenges of patient assistance programs, which provide free or low-cost medicines to eligible patients. They discuss how these programs can improve access, adherence, and outcomes, as well as the operational and regulatory issues involved in running them. Covering key topics such as the Inflation Reduction Act (IRA), the impact of technology and AI in patient services, and the challenges posed by copay accumulators and maximizers, Dave sheds light on the complexities of navigating copay assistance optimization and the strategies employed to mitigate the effects on patients and manufacturers alike.

For more from our Value & Access experts, check out these topics:

Syneos Health Podcast | Real Talk About the Inflation Reduction Act

BLOG: Industry Cheers “Co-Pay Accumulator” Ruling, Should Prep for What’s Next

Potential Impact of European Pharma Legislation on Commercialization and Access of New Therapies

BLOG: What Can We Learn From ICER's New Value Framework

Syneos Health Podcast | Market Access for Weight Loss Drugs

MM+M Podcast | Gaining Access and Delivering Pull-Through in IDNs and Key Accounts

The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.
If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at insightshub.health.
Like what you’re hearing? Be sure to rate and review us!
We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at podcast@syneoshealth.com.

  continue reading

145 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide